首页> 美国政府科技报告 >Nifedipine for Treatment of High Altitude Pulmonary Edema
【24h】

Nifedipine for Treatment of High Altitude Pulmonary Edema

机译:硝苯地平治疗高原肺水肿

获取原文

摘要

In 12 subjects with high altitude pulmonary edema, we studied the effects of 10mgnifedipine on pulmonary and systemic hemodynamics and arterial oxygen saturation. In five of these, repeated dosing was done over 3 hours and spirometry and clinical HAPE scores were also obtained. A single 10mg nifedipine dose lowered pulmonary vascular resistance and pulmonary arterial pressures, as well as systemic arterial pressure and increased SaO2%. Multiple dosing sustained the drug effect, but with a smaller increase SaO2% Clinical scores improved slightly, and within 3 hours there was no consistent effect on spirometry. In addition, we undertook a survey of pulmonary hypertension (PHT) at high altitude, and surprisingly discovered excessive PHT in asymptomatic individuals. We conclude that nifedipine vasodilates the pulmonary bed in persons with HAPE, and that this appears to be beneficial, although short-term improvement was minimal. Since asymptomatic PHT is common, factors other than PHT are critical in HAPE pathogenesis, and by extension, could be important in prevention and treatment. Altitude, High Altitude Pulmonary Edema, HAPE, Nifedipine, Hypoxic Pulmonary Hypertension, RA III, Volunteers.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号